poor response and very ill patients may have been treated (off-protocol and excluded) prior to transfer. Other series also include Stage II patients and the long-term survival of Stage II patients in the BNLI CHOP studies is nearly twice that of Stage III/IV patients. Confusion also exists over histology and many series include diffuse small cleaved-cell lymphomas, a category that would be considered as low-grade by the BNLI. Furthermore, some centres exclude patients who do not receive certain quantities of drugs, thus eliminating early deaths. It must therefore be concluded that there is as yet no firm proof that any of these regimens are superior to CHOP. There is clearly a desperate need for a large randomized controlled trial in this field. At present the BNLI is investigating the use of IMVP16 or very high-dose chemotherapy with autologous bone marrow rescue in those patients not in CR after 3 courses of CHOP as a prelude to such a randomized trial.
The final paper of the session, given by Professor T J McElwain from the Institute of Cancer Research and Royal Marsden Hospital, was on 'Hodgkin's disease in childhood'. This has a good prognosis, with 90% of patients being disease-free and probably cured after modern treatment. With effective combination therapy it is no longer necessary to document occult disease in the abdomen by staging laparotomy and splenectomy, which in childhood carries a major risk of subsequent morbidity due to pneumococcal and H. influenzae septicaemia. Nor is it necessary to use extended field radiotherapy for patients with early stage disease. This is associated with inhibition of bone growth and should be avoided where possible. Favourable Stage I disease (high cervical nodes, not bulky and not lymphocyte-depleted histology) can be treated with involved field radiation, and the few who relapse can be expected to be cured by combination chemotherapy. This approach to treatment is a sub-ject of a study currently organized by the United Kingdom Cancer Study Group. Unfavourable Stage I, most Stage II and all Stage III disease should be treated with chemotherapy. There is evidence that irradiation of bulky disease above the diaphragm following chemotherapy is associated with a low relapse rate. Stage IIA disease with small-volume cervical nodes or inguinal nodes only can be treated with involved field irradiation and any relapses retrieved with chemotherapy. Stage IV disease needs chemotherapy and here new agents and combinations of chemotherapy need to be explored in children who relapse or who have poor prognosis disease. The aim of such chemotherapy programmes is to reduce the carcinogenic risk associated with alkylating agents and procarbazine and also to develop programmes which do not sterilize males. Since, with most commonly used chemotherapy combinations, the most important late side effect is likely to be the induction of acute myeloblastic leukaemia and possibly other tumours, it is essential to assess this risk in children during the next few years, as has been done in adults.
Professor R J Berry closed the meeting by saying that the treatment of lymphoma has been one of the great success stories of modem cancer managementa success brought about by a fusion of traditional skills and new diagnostic and therapeutic techniques. While much has been achieved, much more remains to be done. The gains will be smaller but nonetheless worthwhile -minimizing upsetting treatment for those not needing it and maximizing effective treatment for those who do. It is still a challenging prospect. To Professor Tom Stapleton, President of the Section of Paediatrics, must go all the credit and more for the inspiration and organization of this meeting, probably the most ambitious event ever organized by the Section of Paediatrics. In particular, getting a large number of Chinese speakers to attend was a remarkable diplomatic and organizational achievement. The opening session was honoured by the presence of HRH The Princess Anne, and the twoday meeting comprised 16 papers from the People's Republic of China, 4 from Africa, 6 from the UK, and a series of posters, films, and a video.
Gillian Vaughan Hudson
The meeting opened with papers on general topics. A number of special topics were covered. Dr X Meng (Heilongjang, China) described the clinical and pathological features of Keshan disease, a form of cardiomyopathy endemic in certain parts of China.
Professor J Goodwin (Royal Postgraduate Medical School, London) gave a short paper on cardiomyopathy, and expanded the discussion on the possible role of selenium deficiency in the aetiology of Keshan disease. There were papers on plasmid profiles in staphylococcal infections (Dr J Tang, Chongquing, China), beta-haemolytic streptococcal carriage in mothers and neonates in Kenya (Dr J S Meme, Nairobi), and an analysis of 200 cases of cardiac catheterization in children (Dr M Kang, Hangzhou, China). A paper on studies using monoclonal antibodies against adenovirus type 7 by Dr CHao (Jilin Province, China) led to a discussion about the role of certain adenoviruses in causing lung damage. A paper on the incidence of rickets, vitamin D overdose and anaemia in Beijing (Dr T Li, Beijing, China) was followed by information about iron deficiency in Hangzhou (Dr Q Sun, Zhejiang Province, China).
Then Professor P C Elwood (Director, 'MRC Epidemiology Research Unit, Cardiff) presented some salient facts about iron supplementation. The practice in certain parts of China of increasing the consumption of eggs as a treatment for iron deficiency turned out to be an unhelpful approach, as it appears that the iron in eggs, although plentiful, is not biologically available. Indeed, studies described by Professor Elwood showed that eggs also greatly reduce the absorption of iron from other foods in the diet. The audience also learnt of the pitfalls of iron fortification of bread in the UK, and Professor Elwood finally questioned the desirability of iron supplementation to treat asymptomatic iron deficiency. He pointed out that whilst it was easy enough to introduce extra iron into food, it was difficult to evaluate the benefits or disadvantages. Finally, Dr B Wharton (Birmingham) drew our attention to work indicating that 'asymptomatic' iron deficiency in childhood may be associated with impaired cognitive function, which may be reversed after iron supplementation. It was fitting that the first day should conclude with Professor Tom Stapleton's Presidential Address entitled 'The youth of the world: have they lost their way?' A paper on idiopathic thrombocytopenic purpura (Dr J Li and Professor L Wang, Wuhan, China) was followed by.a very lucid report of recent trends in child health and survival in Zimbabwe (Dr F K Nkrumah and Dr K J Nathoo, Harare). A provocative presentation on factors influencing intelligence and physical development (Professor Z Gu, Xinjiang, China) was followed by reports on perinatal care (Dr H Ye, Beijing, China), follow up of premature infants (Dr Y Lu, General Hospital of the Air Force, China), and haemoglobinopathies in Sichuan (Dr Y Geng and Dr J Zhang). A paper on how to design hospitals in developing countries was given by Mr M Wells (Medical Building Design Unit, Department of Epidemiology and Community Medicine, University of Bristol), and this was accompanied by an excellent set of posters. Mr Wells described the process of planning and design, and he had some pertinent observations to make about the layout of consulting rooms and paediatric wards.
Early in 1986, a team of five professors of genetics from the UK visited China, and the meeting closed with short papers by Professors K M Laurence, N Nevin. D Roberts and R Harris describing the visit to Beijing and Shanghai. It appeared that the overall incidence of congenital malformations in China was similar to that of the UK, although it was pointed out that certain genetic disorders such as cystic fibrosis, galactosaemia, coeliac disease and Huntington's chorea are almost unknown in China. Professor Roberts pointed out the problems of a country whose population (1015 million) comprises one-quarter of the world's population, and whose numbers were constant between 1840 and 1940 and have doubled since then. He described the proposed eugenic law, which would prohibit marriage or reproduction in the case of certain genetic or psychiatric conditions. The similarity between the proposed law and the situation obtaining in Germany not so long ago was pointed out, and Professors Roberts and Harris both suggested an alternative of comprehensive genetic services, thus avoiding the need to infringe an individual's right to choose.
One of the strongest impressions of this remarkable meeting was Princess Anne's dedication to the problems of developing countries. After an overnight flight from Montreal she had arrived in London at 8.45 am, by which time most would be flagging, but she came to the RSM in time for the start of the meeting at 10.00am. Her lively and well informed comments typified the outstanding contribution that the Princess is making in the field ofchild health and welfare worldwide. Some of her interest has rubbed off on those around her. Over lunch we met a police inspector, assigned to the Princess for the last five years, who must, I imagine, be about the only policeman in the UK with whom one could discuss primary health care and vaccination problems in the Gambia! 
